BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang T, Wang H, Yang F, Gao K, Luo S, Bai L, Ma K, Liu M, Wu S, Wang H, Chen Z, Xiao Q. Honokiol inhibits proliferation of colorectal cancer cells by targeting anoctamin 1/TMEM16A Ca2+ -activated Cl- channels. Br J Pharmacol 2021. [PMID: 34192810 DOI: 10.1111/bph.15606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Shao G, Hong X, Shi Y, Zheng Y, Yu Y, Fu C. Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway. Pharmaceuticals (Basel) 2023;16. [PMID: 36678567 DOI: 10.3390/ph16010070] [Reference Citation Analysis]
2 Dewdney B, Ursich L, Fletcher EV, Johns TG. Anoctamins and Calcium Signalling: An Obstacle to EGFR Targeted Therapy in Glioblastoma? Cancers (Basel) 2022;14. [PMID: 36497413 DOI: 10.3390/cancers14235932] [Reference Citation Analysis]
3 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
4 Shi S, Ma B, Sun F, Qu C, Li G, Shi D, Liu W, Zhang H, An H. Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity. J Biol Chem 2022;298:101731. [PMID: 35176281 DOI: 10.1016/j.jbc.2022.101731] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Schreiber R, Cabrita I, Kunzelmann K. Paneth Cell Secretion in vivo Requires Expression of Tmem16a and Tmem16f. Gastro Hep Advances 2022;1:1088-1098. [DOI: 10.1016/j.gastha.2022.08.002] [Reference Citation Analysis]